AB002
A recombinant antithrombotic and cytoprotective enzyme that acts without increasing the risk of bleeding. AB002 is in pre-clinical development for stand-alone emergency use during acute cardiovascular and cerebral ischemia.
AB012
A recombinant protein that selectively inhibits the intrinsic blood coagulation cascade upstream of coagulation factor IX (F9). AB012 is in pre-clinical development for use as an antithrombotic agent when the bleeding risk is moderate.
AB022
A recombinant protein that selectively inhibits the intrinsic coagulation cascade upstream of coagulation factor XI (F11). AB022 is in pre-clinical development for use in conditions that are intrinsically accompanied with bleeding, such as major surgeries and consumptive coagulopathy.